Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K11 | Q16584 | 1/20 | 0.44 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.43 |
| ▸ | JAK1 | P23458 | 1/20 | 0.43 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.43 |
| ▸ | JAK3 | P52333 | 4/20 | 0.43 |
| ▸ | JAK2 | O60674 | 2/20 | 0.43 |
| ▸ | MAPK8 | P45983 | 10/20 | 0.42 |
| ▸ | MAPK9 | P45984 | 10/20 | 0.42 |
| ▸ | JUN | P05412 | 9/20 | 0.42 |
| ▸ | CDK2 | P24941 | 9/20 | 0.42 |
| ▸ | MAPK10 | P53779 | 6/20 | 0.42 |
| ▸ | CLK2 | P49760 | 1/20 | 0.42 |
| ▸ | CLK3 | P49761 | 1/20 | 0.42 |
| ▸ | FLT3 | P36888 | 1/20 | 0.41 |
| ▸ | CDK1 | P06493 | 1/20 | 0.41 |
| ▸ | CDK4 | P11802 | 1/20 | 0.41 |
| ▸ | CCND1 | P24385 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30347891 | 1.00 | MAP3K11 (0.44) | MAP3K11DYRK1AJAK1DYRK1BJAK3 | |
| SCHEMBL30347890 | 0.89 | MAP3K11 (0.41) | MAP3K11DYRK1ADYRK1BMAPK8MAPK9 | |
| SCHEMBL25522655 | 0.89 | MAP3K11 (0.41) | MAP3K11DYRK1ADYRK1BMAPK8MAPK9 | |
| SCHEMBL25522659 | 0.89 | DYRK1A (0.38) | MAP3K11DYRK1ADYRK1BJAK3MAPK8 | |
| SCHEMBL30348774 | 0.89 | DYRK1A (0.38) | MAP3K11DYRK1ADYRK1BJAK3MAPK8 | |
| SCHEMBL25522526 | 0.88 | DYRK1A (0.42) | MAP3K11DYRK1AJAK1DYRK1BJAK3 | |
| SCHEMBL31568822 | 0.88 | DYRK1A (0.42) | MAP3K11DYRK1AJAK1DYRK1BJAK3 | |
| SCHEMBL25201523 | 0.88 | DYRK1A (0.55) | DYRK1ADYRK1BMAPK8MAPK9JUN | |
| SCHEMBL30349412 | 0.88 | DYRK1A (0.55) | DYRK1ADYRK1BMAPK8MAPK9JUN | |
| SCHEMBL30346692 | 0.88 | DYRK1A (0.40) | MAP3K11DYRK1AJAK1DYRK1BJAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230167133-A1 | 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF | VICKERS VENTURE FUND VI PTE. LTD. (SG) | 2023-06-01 | — | — | US | disclosed |
| US-20230167133-A1 | 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF | VICKERS VENTURE FUND VI PTE. LTD. (SG) | 2023-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230167133-A1 | 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF | DYRK1A, DYRK1B, DYRK2 | MAP3K11 203/4885DYRK1A 1/4885JAK1 988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.